Evidence map›Paper›PMID 26440668›Full record

ArticleMolecular neurobiology2016

Inositol Hexakisphosphate Kinase 2 Promotes Cell Death in Cells with Cytoplasmic TDP-43 Aggregation.

Eiichiro Nagata, Takashi Nonaka, Yusuke Moriya, Natsuko Fujii, Yoshinori Okada, Hideo Tsukamoto, Johbu Itoh, Chisa Okada, Tadayuki Satoh, Tetsuaki Arai and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Molecular neurobiology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Elevation of inositol pyrophosphate IPFrontiers in neurology · 2023
    Article
  6. Article
  7. Article
  8. Article
  9. The Key Role of IPMolecules (Basel, Switzerland) · 2020
    Review
  10. Article
  11. The inositol pyrophosphate pathway in health and diseases.Biological reviews of the Cambridge Philosophical Society · 2018
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Eiichiro NagataDepartment of Neurology, Tokai University School of Medicine, Isehara, Japan. enagata@is.icc.u-tokai.ac.jp.
Takashi NonakaDepartment of Neuropathology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Yusuke MoriyaDepartment of Neurology, Tokai University School of Medicine, Isehara, Japan.
Natsuko FujiiDepartment of Neurology, Tokai University School of Medicine, Isehara, Japan.
Yoshinori OkadaSupport Center for Medical Research and Education, Tokai University, Isehara, Japan.
Hideo TsukamotoSupport Center for Medical Research and Education, Tokai University, Isehara, Japan.
Johbu ItohSupport Center for Medical Research and Education, Tokai University, Isehara, Japan.
Chisa OkadaSupport Center for Medical Research and Education, Tokai University, Isehara, Japan.
Tadayuki SatohSupport Center for Medical Research and Education, Tokai University, Isehara, Japan.
Tetsuaki AraiDepartment of Neuropsychiatry, Division of Clinical Medicine, Faculty of Medicine, University of Tsukuba, Tsukuba, Japan.
Masato HasegawaDepartment of Neuropathology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan.
Shunya TakizawaDepartment of Neurology, Tokai University School of Medicine, Isehara, Japan.
Tokai University · JPTokyo Metropolitan Institute of Medical Science · JPUniversity of Tsukuba · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

TAR DNA-binding protein 43 (TDP-43) has been identified as a major component of ubiquitin-positive inclusions in the brains and spinal cords of patients with frontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U) or amyotrophic lateral sclerosis (ALS). The phosphorylated C-terminal fragment of TDP-43 forms aggregates in the neuronal cytoplasm, possibly resulting in neuronal cell death in patients with FTLD-U or ALS. The inositol pyrophosphate known as diphosphoinositol pentakisphosphate (InsP7) contains highly energetic pyrophosphate bonds. We previously reported that inositol hexakisphosphate kinase type 2 (InsP6K2), which converts inositol hexakisphosphate (InsP6) to InsP7, mediates cell death in mammalian cells. Moreover, InsP6K2 is translocated from the nucleus to the cytosol during apoptosis. In this study, we verified that phosphorylated TDP-43 co-localized and co-bound with InsP6K2 in the cytoplasm of anterior horn cells of the spinal cord. Furthermore, we verified that cell death was augmented in the presence of cytoplasmic TDP-43 aggregations and activated InsP6K2. However, cells with only cytoplasmic TDP-43 aggregation survived because Akt activity increased. In the presence of both TDP-43 aggregation and activated InsP6K2 in the cytoplasm of cells, the expression levels of HSP90 and casein kinase 2 decreased, as the activity of Akt decreased. These conditions may promote cell death. Thus, InsP6K2 could cause neuronal cell death in patients with FTLD-U or ALS. Moreover, InsP6K2 plays an important role in a novel cell death pathway present in FTLD-U and ALS.

Indexed as

Protein AggregatesCasein Kinase IICell DeathCell Line, TumorCell NucleusCytoplasmDNA-Binding ProteinsHSP70 Heat-Shock ProteinsHSP90 Heat-Shock ProteinsHumansPhosphorylationPhosphotransferases (Phosphate Group Acceptor)Proto-Oncogene Proteins c-aktCasein Kinase IIDNA-Binding ProteinsHSP70 Heat-Shock ProteinsHSP90 Heat-Shock Proteinsinositol hexakisphosphate kinasePhosphotransferases (Phosphate Group Acceptor)Protein AggregatesProto-Oncogene Proteins c-aktAktAmyotrophic lateral sclerosis (ALS)Casein kinase 2Cell deathFrontotemporal lobar degeneration with ubiquitinated inclusions (FTLD-U)HSP90Inositol hexakisphosphate kinase 2 (InsP6K2)TDP-43

Identifiers

PMID26440668
OpenAlexW2173592104

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.